Pavlos Msaouel: The second Msaouel Lab R01 proposal has been funded to investigate Renal Medullary Carcinoma
Pavlos Msaouel, Physician-Scientist at Msaouel Lab, shared on X:
“The second Msaouel Lab R01 proposal has now been funded to investigate Renal Medullary Carcinoma as a model to understand and target key cancer hallmarks.
This one is a multiPI collaborative effort with each team synergizing to identify unifying principles.”
Petros Grivas sent his congratulations:
“Congratulations Pavlos Msaouel and team! This is truly fantastic and so well deserved!”
Source: Pavlos Msaouel/X, Petros Grivas/X and Mohammad Jad Moussa/X
Dr. Petros Grivas, a board-certified medical oncologist, serves as Clinical Director of the Genitourinary Cancers Program at the University of Washington and Seattle Cancer Care Alliance. He’s an Associate Professor at the Dept. of Medicine and Associate Member at Fred Hutchinson Cancer Research Center since January 2018. With extensive training and experience, he’s led clinical trials, contributing to FDA approvals for bladder/urothelial cancer treatments.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023